IQVIA completes acquisition of Q2 Diagnostics

IQVIA completes acquisition of Q2 Diagnostics
The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.
IQVIA Holdings, which provides analytics, technology solutions and clinical research services to life-science clients, has acquired the remaining 40% of Q2 Solutions from diagnostic information services provider Quest Diagnostics. The companies report that $760m changed hands in the deal, via cash on hand.
Brian O’Dwyer, Q2 Solutions CEO, spoke with Outsourcing-Pharma about the transaction and what it means for both firms, and their industry clients. According to O’Dwyer, IQVIA will benefit from the acquired company’s broad range of services and expertise.

Related Keywords

Brian Odwyer , Bo Brian Odwyer , Iqvia Holdings , Quest Diagnostics , Briano Dwyer , Markets Amp Regulations , Clinical Development , Consolidation , Analytical Testing , Hqc , Data Management , Phasei Ii , Phase Iii Iv , Preclinical , Iqvia , Diagnostics , Testing , Laboratory , Mergers And Acquisitions , தேடலை பரிசோதனை , சந்தைகள் ஆம்ப் ஒழுங்குமுறைகள் , மருத்துவ வளர்ச்சி , ஒருங்கிணைப்பு , பகுப்பாய்வு சோதனை , க்ஸீ , தகவல்கள் மேலாண்மை , கட்டம் ஈயீ இவ் , பரிசோதனை , சோதனை , ஆய்வகம் , இணைப்புகள் மற்றும் கையகப்படுத்துதல் ,